// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
The quality of medicine and how it’s delivered to patients is fundamental to treating illness and
For people living in rural areas of the U.S., access to healthcare providers can be a serious cha
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis